🦊/Investors

MarsBio

Venture capital

Los Angeles · 3 people tracked

Find your way into MarsBio

40 people in our graph share verified history with the MarsBio team — schools, employers, funds. One of them is your warm intro.

Amir Dan Rubinunlockedknows Arye Lipman · together at UCLA Medical Center (overlapped)
×3knows the team · via UCLA Medical Center
×2knows the team · via XEIA Venture Partners
knows the team · via UC Santa Barbara
×5knows the team · via imec
Fox Verdict
Sign up to see your fit

Fund manager profile

MarsBio is a venture fund manager based in Los Angeles. SEC filings show 1 venture fund on record, most recently MarsBio Fund I L.P. ($50M offering) filed March 2019.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Los Angeles, US
Founded
2018
Tracked investments
1

Team · 3 people

from public directories
Llewellyn Cox· General Partner
Robert Rhinehart· General Partner

What they invest in

from 1 of 1 portfolio companies

AgTech ×1Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
NapiGennapigen.comin𝕏Jul 2022 · $7.9M

Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.

AgTechBiotechWilmington, US

Co-investorsRA CapitalThe Innovation SpaceGrantham Foundation

Frequently asked questions

Where is MarsBio located?
MarsBio is headquartered in Los Angeles, US.

Media · Podcasts & interviews

featuring the team

Networking Corner with Arye Lipman, General Partner at MarsBio: “Commercialization of Science”

alumniucla · Arye Lipman

Co-investors · 1

VU Venture Partners

VU Venture Partners is a global early-stage technology venture capital fund investing across the world's largest market opportunities, operating with a large investment team and six vertical-focused practices.

$200K – $1M

Firms observed investing alongside MarsBio, from public investor directories. Shared companies are the overlap with MarsBio's recorded portfolio.

Featured in lists